Genomine Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 5

Genomine General Information

Description

Operator of a research and development company intended to discover functional genes. The company discovers disease markers that are based on functional dielectric, proteome analysis and create high added value through technology transfer and is utilized in businesses as well as focused on discovering the novel plant genes related to yield increase, environmental stress, and lethality, thereby enabling researchers and agriculture owners to transform crop and crop protection crab business based on gene discovery and utilization technology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Primary Office
  • Number 307, Venture-dong, Pohang Techno Park
  • 394, Jigok-ro, Nam-gu
  • Pohang-si, Gyeongbuk
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genomine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 02-Jul-2000 Completed Generating Revenue
To view Genomine’s complete valuation and funding history, request access »

Genomine Patents

Genomine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2894474-A1 Method and kit for detecting renal cancer blood biomarkers Granted 07-Sep-2012 000000000000
EP-2894474-B1 Use of specific binding molecules and of respective kit for detecting renal cancer blood biomarkers Active 07-Sep-2012 000000000000
EP-2894474-A4 Method and kit for detecting renal cancer blood biomarkers Granted 07-Sep-2012 000000000000 0
US-20110131683-A1 Polypeptide inducing dwarfism of plants, polynucleotide coding the polypeptide, and those use Abandoned 13-Nov-2007 0000000000
EP-2115142-A4 Polypeptide having methionine synthesis function, polynucleotide encoding the polypeptide, and those use Withdrawn 19-Dec-2006 C12N9/88 0
To view Genomine’s complete patent history, request access »

Genomine Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Hyundai Securities Limited Partner Minority 000 0000 000000 0
Hyundai Technology Investment Other Minority 000 0000 000000 0
Hyundai Venture Investment Corporation Corporate Venture Capital Minority 000 0000 000000 0
Korea Research Institute of Bioscience and Biotechnology Other Minority 000 0000 000000 0
SK Group Holding Company Minority 000 0000 000000 0
To view Genomine’s complete investors history, request access »